Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation
- PMID: 12820156
- DOI: 10.1002/jps.10402
Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation
Abstract
The in vitro immunosuppressive potency of several therapeutic corticosteroids was investigated using a whole-blood lymphocyte proliferation assay. The selected steroids included beclomethasone dipropionate (BDP), betamethasone (BET), budesonide (BUD), dexamethasone (DEX), flunisolide (FLU), fluticasone propionate (FTP), hydrocortisone (HC), methylprednisolone (MPL), prednisolone (PNL), and triamcinolone acetonide (TAA). The ability of phytohemagglutinin to stimulate lymphocytes in whole blood samples obtained from six drug-free male volunteers was tested against drug concentrations ranging from approximately 0.2 to 2000 nM. Data analysis was conducted employing an inhibitory Hill function and nonlinear regression analysis in ADAPT II. The order of drug concentrations producing 50% inhibition (IC(50)) from highest to lowest was HC > PNL > MPL > BDP > BET > DEX > TAA > FLU > BUD > FTP. These IC(50) values are an inverse measure of drug potency, with FTP representing the most potent corticosteroid examined. A linear correlation was found between the log-transformed 1/IC(50) values and the log of the relative receptor affinity (RRA) values obtained from the literature (r(2) = 0.95). These results extend previous studies to include relatively new corticosteroids and further support the use of RRA values as an indirect measure of relative in vitro immunosuppressive potency.
Copyright 2003 Wiley-Liss, Inc. and the American Pharmacists Association
Similar articles
-
Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: modeling interoccasion pharmacodynamic variability.Pharm Res. 2007 Jun;24(6):1088-97. doi: 10.1007/s11095-006-9232-x. Epub 2007 Mar 24. Pharm Res. 2007. PMID: 17385022 Free PMC article. Clinical Trial.
-
Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone.Jpn J Ophthalmol. 2004 May-Jun;48(3):236-42. doi: 10.1007/s10384-003-0053-8. Jpn J Ophthalmol. 2004. PMID: 15175915
-
Immunosuppressive interactions among calcium channel antagonists and selected corticosteroids and macrolides using human whole blood lymphocytes.Drug Metab Pharmacokinet. 2004 Dec;19(6):413-21. doi: 10.2133/dmpk.19.413. Drug Metab Pharmacokinet. 2004. PMID: 15681895 Free PMC article. Clinical Trial.
-
Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications.Allergy. 2008 Oct;63(10):1292-300. doi: 10.1111/j.1398-9995.2008.01750.x. Allergy. 2008. PMID: 18782107 Review.
-
Comparative efficacy and safety of inhaled corticosteroids in asthma.Can J Clin Pharmacol. 1999 Spring;6(1):26-37. Can J Clin Pharmacol. 1999. PMID: 10465863 Review.
Cited by
-
Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS.J Intensive Care. 2018 Aug 24;6:53. doi: 10.1186/s40560-018-0321-9. eCollection 2018. J Intensive Care. 2018. PMID: 30155260 Free PMC article.
-
Regulatory effects of dexamethasone on NK and T cell immunity.Inflammopharmacology. 2018 Oct;26(5):1331-1338. doi: 10.1007/s10787-017-0418-0. Epub 2017 Nov 20. Inflammopharmacology. 2018. PMID: 29159714 Free PMC article.
-
Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.Clin Pharmacokinet. 2005;44(1):61-98. doi: 10.2165/00003088-200544010-00003. Clin Pharmacokinet. 2005. PMID: 15634032 Review.
-
Effects of representative glucocorticoids on TNFα- and CD40L-induced NF-κB activation in sensor cells.Steroids. 2014 Jul;85:36-43. doi: 10.1016/j.steroids.2014.04.003. Epub 2014 Apr 18. Steroids. 2014. PMID: 24747770 Free PMC article.
-
Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen.Drug Metab Dispos. 2017 Jul;45(7):834-845. doi: 10.1124/dmd.117.075614. Epub 2017 Apr 17. Drug Metab Dispos. 2017. PMID: 28416614 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical